Disc Medicine (IRON) Shares Issued (2020 - 2026)
Disc Medicine (IRON) reported Shares Issued of $1.0 million for Q1 2026, up 75.65% year-over-year from $575000.0 in Q1 2025, and down 87.47% on a QoQ basis from $8.1 million in Q4 2025.
Disc Medicine (IRON) has 7 years of Shares Issued data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Shares Issued rose 75.65% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 174.53% YoY) and the FY2025 annual result came in at $8.6 million, up 190.36% from the prior year.
- Shares Issued slipped to $1.0 million in Q1 2026 per IRON's latest filing, from $8.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $53.3 million in Q4 2022 and bottomed at -$932000.0 in Q3 2024.
- The 5-year median for Shares Issued is $575000.0 (2025), against an average of $4.0 million.
- The widest annual swing landed in 2022, when Shares Issued jumped 127092.86%; it then plunged 250.81% in 2024.
- Tracing IRON's Shares Issued over 5 years: stood at $53.3 million in 2022, then sank by 98.49% to $806000.0 in 2023, then surged by 214.52% to $2.5 million in 2024, then surged by 218.07% to $8.1 million in 2025, then plunged by 87.47% to $1.0 million in 2026.
- Per Business Quant, the three latest IRON Shares Issued figures stand at $1.0 million (Q1 2026), $8.1 million (Q4 2025), and $291000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 8.06 Mn |
| Dec 31, 2025 | 8.06 Mn |
| Sep 30, 2025 | 291,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | -288,000.00 |
| Jun 30, 2025 | -288,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Dec 31, 2024 | 2.54 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | -932,000.00 |
| Sep 30, 2024 | -932,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 245,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 806,000.00 |
| Dec 31, 2023 | 806,000.00 |
| Sep 30, 2023 | 618,000.00 |
| Sep 30, 2023 | 618,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 222,000.00 |
| Mar 31, 2023 | 222,000.00 |
| Dec 31, 2022 | 53.34 Mn |
| Dec 31, 2022 | 53.34 Mn |
| Sep 30, 2022 | 22,000.00 |
| Sep 30, 2022 | 22,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | 55,000.00 |
| Mar 31, 2022 | 55,000.00 |
| Dec 31, 2021 | -42,000.00 |
| Dec 31, 2021 | -42,000.00 |
| Jun 30, 2021 | 106,000.00 |
| Jun 30, 2021 | 106,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 120.75 Mn |
| Dec 31, 2020 | 120.75 Mn |
| Sep 30, 2020 | 4.42 Mn |
| Sep 30, 2020 | 4.42 Mn |
| Jun 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |